Florian Schönharting possesses over 22 years investment executive experience in both public and private equity funds in biotech and pharmaceuticals, co-founder of NB Capital, prior to this 10 years as key responsible for biopharma public and private investments, BankInvest Asset Management, Actively managed BI Healthcare SICAV and BI Bioteknologi SICAV for 8 years. Currently managed funds are NB Public Equity K/S, Nordic Biotech l & ll. Founder and co-founder of several biotechnology companies including Genmab A/S, Life Cycle Pharma A/S, Zealand Pharma A/S. Overall Group CEO for NB Capital ApS. and largest shareholder.
Biotech and pharmaceuticals